Turn Therapeutics (TTRX) Enterprise Value (2024 - 2026)

Turn Therapeutics' Enterprise Value history runs 3 years deep, the most recent figure standing at -$11.0 million for Q1 2026.

• In Q1 2026, Enterprise Value changed N/A year-over-year to -$11.0 million; the TTM figure through Mar 2026 stood at -$11.0 million (changed N/A YoY), while the FY2025 annual figure was -$4.0 million, down 708.34% from the prior year.
• Enterprise Value was -$11.0 million for Q1 2026 at Turn Therapeutics, down from -$4.0 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$498286.0 in Q3 2024 to a low of -$11.0 million in Q1 2026.
• Historically, Enterprise Value has averaged -$3.3 million across 3 years, with a median of -$513695.0 in 2025.
• Biggest YoY gain for Enterprise Value was 3.09% in 2025; the steepest drop was 708.34% in 2025.
• A 3-year view of Enterprise Value shows it stood at -$498286.0 in 2024, then tumbled by 708.34% to -$4.0 million in 2025, then tumbled by 173.33% to -$11.0 million in 2026.
• The last three Enterprise Value figures came in at -$11.0 million (Q1 2026), -$4.0 million (Q4 2025), and -$513695.0 (Q3 2025), per Business Quant data.